Stryker stock forecast
Stryker's weighted forecast is $306.07 by October 2027, a 10% return, and $367.19 by October 2029, a 34% return, dividends included. Stryker's outcome hinges on earnings delivery and the valuation multiple.
Where could Stryker's shares be by October 2029?
The weighted forecast is $306.07 by October 2027, a 10% return, and $367.19 by October 2029, a 34% return, dividends included. It assigns 25% probability to the bear case, 55% to base and 20% to bull.
By October 2029, the bear case reaches $198.91, while the bull case reaches $613.37. Today’s price is $281.63, so earnings delivery and the valuation multiple matter much more than the small differences in share count or dividend growth.
| Case | Probability | October 2027 | October 2028 | October 2029 |
|---|---|---|---|---|
| Bear | 25 % | 230.52 (-17 %) | 210.59 (-23 %) | 198.91 (-26 %) |
| Base | 55 % | 311.02 (+12 %) | 333.91 (+21 %) | 354.16 (+30 %) |
| Bull | 20 % | 386.92 (+39 %) | 489.12 (+76 %) | 613.37 (+122 %) |
| Weighted | 100 % | 306.07 (+10 %) | 334.12 (+21 %) | 367.19 (+34 %) |
What has to go right or wrong for Stryker?
The bear case gives $4,233 million in 2027 and $4,530 million in 2028, reaching $4,834 million in 2029. Its margins remain below the normalized 2025 level because cyber recovery, Inari supply issues, price pressure and acquisition costs persist. The bull case rises from $5,134 million in 2027 to $6,084 million in 2028 and $7,182 million in 2029. It requires faster procedure growth, stronger Mako utilization and margin gains ahead of plan. Net debt was $11,466 million in June 2026, so financing and integration demands limit confidence in that path.
| October 2027 | October 2028 | October 2029 | |
|---|---|---|---|
| Earnings | 4,792 (4,233 / 5,134) | 5,376 (4,530 / 6,084) | 5,968 (4,834 / 7,182) |
| Shares (millions) | 385 (386 / 385) | 386 (387 / 386) | 388 (389 / 386) |
| Dividends per share | 3.69 (3.52 / 3.76) | 3.87 (3.52 / 4.06) | 4.06 (3.52 / 4.39) |
| Price to earnings | 25.00 (21.00 / 29.00) | 24.00 (18.00 / 31.00) | 23.00 (16.00 / 33.00) |
How much cash does Stryker really make?
Stock compensation is another shareholder cost. The company recorded $243 million of it in 2025. Because employees receive ownership claims rather than immediate cash, the cash-flow statement adds the expense back. But new shares can dilute existing owners. Subtracting that cost produces a shareholder-focused free-cash-flow figure of $4,040 million.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | 5,044 | 4,242 | 3,711 | 2,624 | 3,263 |
| − Capital spending | 761 | 755 | 575 | 588 | 525 |
| = Free cash flow | 4,283 | 3,487 | 3,136 | 2,036 | 2,738 |
| − Stock pay | 243 | 229 | 205 | 168 | 171 |
| = Real free cash flow | 4,040 | 3,258 | 2,931 | 1,868 | 2,567 |
| Real free cash flow, % of revenue | 16.1% | 14.4% | 14.3% | 10.1% | 15.0% |
What this means. The company's own free cash flow is higher because it leaves out recall payments and sometimes includes money from selling assets, while our count includes those cash effects.
What does an investor pay for Stryker today?
Free cash flow provides another test. Stryker generated $5.044 billion from operations and spent $761 million on property and equipment in 2025. But acquisitions consumed $4.960 billion. That explains why a 4.0% free-cash-flow yield is not the same as a 1.2% dividend yield: the company can use cash for acquisitions, debt repayment or reinvestment before shareholders receive it.